WELITEL-H contains Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg, combining an ARB with a thiazide diuretic for complementary blood-pressure control. A dependable PCD Cardiac-Diabetic offering.
To provide additional BP reduction through diuresis.
It may, especially initially.
Monitor BP, hydration and electrolytes as clinically appropriate. Inform the physician about kidney disease or significant dehydration.
Dizziness, weakness, increased urination, electrolyte disturbances, headache and dehydration may occur.
WELITEL-H: Telmisartan produces vasodilation by blocking angiotensin-II receptors, while Hydrochlorothiazide promotes sodium and water excretion, reducing circulating volume.
